WallStreetZenWallStreetZen

NASDAQ: ETNB
89bio Inc Stock

$7.91+0.12 (+1.54%)
Updated Oct 14, 2024
ETNB Price
$7.91
Fair Value Price
$4.06
Market Cap
$837.75M
52 Week Low
$6.58
52 Week High
$16.63
P/E
-4.02x
P/B
1.63x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$174.61M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.13
Operating Cash Flow
-$166M
Beta
0.93
Next Earnings
Nov 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ETNB Overview

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ETNB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ETNB ($7.91) is overvalued by 94.77% relative to our estimate of its Fair Value price of $4.06 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ETNB ($7.91) is not significantly undervalued (94.77%) relative to our estimate of its Fair Value price of $4.06 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ETNB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ETNB due diligence checks available for Premium users.

Be the first to know about important ETNB news, forecast changes, insider trades & much more!

ETNB News

Valuation

ETNB fair value

Fair Value of ETNB stock based on Discounted Cash Flow (DCF)
Price
$7.91
Fair Value
$4.06
Overvalued by
94.77%
ETNB ($7.91) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ETNB ($7.91) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ETNB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ETNB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.02x
Industry
-124.07x
Market
27.44x

ETNB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.63x
Industry
6.12x
ETNB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ETNB's financial health

Profit margin

Revenue
$0.0
Net Income
-$48.0M
Profit Margin
0%
ETNB's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$582.1M
Liabilities
$67.2M
Debt to equity
0.13
ETNB's short-term assets ($579.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ETNB's short-term assets ($579.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ETNB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$61.2M
Investing
$27.8M
Financing
$28.0M
ETNB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ETNB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ETNB$837.75M+1.54%-4.02x1.63x
PLRX$834.80M+0.59%-4.44x2.13x
MDXG$841.22M+0.35%8.95x5.01x
LQDA$855.10M+0.45%-7.09x13.63x
SLN$876.83M-4.43%N/A6.08x

89bio Stock FAQ

What is 89bio's quote symbol?

(NASDAQ: ETNB) 89bio trades on the NASDAQ under the ticker symbol ETNB. 89bio stock quotes can also be displayed as NASDAQ: ETNB.

If you're new to stock investing, here's how to buy 89bio stock.

What is the 52 week high and low for 89bio (NASDAQ: ETNB)?

(NASDAQ: ETNB) 89bio's 52-week high was $16.63, and its 52-week low was $6.58. It is currently -52.44% from its 52-week high and 20.3% from its 52-week low.

How much is 89bio stock worth today?

(NASDAQ: ETNB) 89bio currently has 105,909,991 outstanding shares. With 89bio stock trading at $7.91 per share, the total value of 89bio stock (market capitalization) is $837.75M.

89bio stock was originally listed at a price of $20.80 in Nov 11, 2019. If you had invested in 89bio stock at $20.80, your return over the last 4 years would have been -61.97%, for an annualized return of -21.47% (not including any dividends or dividend reinvestments).

How much is 89bio's stock price per share?

(NASDAQ: ETNB) 89bio stock price per share is $7.91 today (as of Oct 14, 2024).

What is 89bio's Market Cap?

(NASDAQ: ETNB) 89bio's market cap is $837.75M, as of Oct 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

89bio's market cap is calculated by multiplying ETNB's current stock price of $7.91 by ETNB's total outstanding shares of 105,909,991.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.